
India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says
CNN
Pharmaceutical company Bharat Biotech announced it had concluded the final analysis of its Phase 3 clinical trials, which it called the largest Covid-19 vaccine trial in India.
The trial involved 25,800 participants aged 18 to 98. Of those, 2,433 people were over 60 years old, and 4,500 had comorbidities.
More Related News

Janet Mills and her allies are counting on a gender gap to narrow Platner’s wide lead ahead of the June 9 primary to decide who will face incumbent Republican Sen. Susan Collins. They are betting that the unfiltered style that has brought Platner widespread attention as someone who could help Democrats reach young men will backfire with women.

As a shrinking number of Transportation Security Administration agents work to keep hourslong security lines moving despite not being paid, President Donald Trump stepped into the fray Saturday, announcing he will send Immigration and Customs Enforcement officers to airports by Monday if Congress doesn’t agree to a plan to end the partial government shutdown.











